CLBT earnings call summary

Prepared Highlights

• ARR: 同比增长21%至$493M（CEO），季度净增$12M（CFO）
• 收入: Q1收入$128.3M，同比+19%（CFO）；订阅收入同比+23%（CFO）
• 毛利率: Q1毛利率86%，同比+21%至$110.2M（CFO）
• 调整后EBITDA: Q1 $30.6M，同比+29%，利润率23.9%（190bps扩张）（CFO）
• 自由现金流: 过去12个月FCF $159M，利润率32%，同比+19%（CFO）
• 细分增长率: 美洲+18%，EMEA+25%（其中国防情报中30%+增长），亚太+21%（CEO/CFO）
• 增长产品: Guardian、Pathfinder、Corellium、无人机取证同比增长一倍（CFO）
• 现金: 季末现金及投资$535M，较Q4末基本持平（因收购SCG加拿大）（CFO）
• 员工: 3月底全职员工1,271人（CFO）
• Genesis AI: TAM预估4年约$12.5B；早期采用者超500家、15个国家（CEO）
• FedRAMP: 5月6日获得高等级ATO，由美国司法部赞助（CEO）
• 美国联邦管道: 管道同比增长35%；增长正重回20%+水平（CEO）

Official Guidance (Q2 2026 & Full Year 2026)

• Q2 ARR: $510M–$513M（净新增$17M–$20M，环比+50% mid-point）（CFO）
• Q2 Revenue: $130M–$133M，同比+15%–17%（CFO）
• Q2 Adjusted EBITDA: $29M–$31M，利润率22%–23%（CFO）
• 全年2026: 初始全年指引不变；AI产品收入原假设为零，现预期将有贡献（CEO/CFO）

Mgmt Quotes

• “It would be unethical of me in my job to keep my community safe to not report on this capability ASAP. … Cellebrite Genesis program is not an incremental improvement … it’s a quantum leap.” — 客户邮件（CEO转述）
• “Genesis is the finest digital evidence product I have ever used. … Its ability to process data from mobile phones, computers, documents, CCTV and spreadsheets … would be of potential life-saving value.” — 亚太区客户（CEO转述）
• “Within 15 minutes of ingestion, Genesis identified 16 additional victims previously unknown to investigators. … It is estimated that a manual review … would have required approximately 2 weeks of investigator man hours.” — 美国县警长办公室侦探（CEO转述）
• “A Genesis tenant can now be deployed in a day and training is nonexistent. Nontechnical law enforcement and intelligence officers become instantaneous productive users.” — CEO
• “By the end of the year … we expect our growth products will account for close to 20% of our ARR.” — CFO

Prepared Metrics

Q&A Batch (1-3 of 3)

Q1 — Shaul Eyal

• Topic: AI opportunity and Mythos impact on vulnerability discovery
• Key points:
  • Tom Hogan noted value chain expansion 1 year ago from post-bang crime to intelligence/prevention (Corellium assets); mountain of digital evidence exploding (sensor, surveillance, drone data) while investigator count not growing; AI seen as only way to process this.
  • Anthropic Claude's Mythos raised market concern; mgmt sees it as non-threat: vulnerability discovery ≠ forensically sound evidence extraction; Cellebrite's proprietary hardware-enabled solutions built over 2 decades remain differentiated.
• Mgmt stance: Bullish — AI is a tailwind to be harnessed, not a headwind; Cellebrite's core technology cannot be replicated by LLM with a USB cable.

Q2 — Jeff Van Rhee

• Topic: New product adoption (Guardian Investigate, Genesis) and customer budget/learning curve
• Key points:
  • Guardian Investigate distributed to over 500 registered users; one early adopter solved a crime in 1 minute 12 seconds vs. weeks of investigative work (testimonial at C2C conference).
  • Unknown executive analogized customer migration from free to paid: users quickly see productivity gains and convert to paid versions.
• Mgmt stance: Bullish — powerful word-of-mouth in a small community; product strength drives adoption without traditional PLG motion.

Q3 — Michael Cikos

• Topic: Net new ARR ($12.2M, flattish YoY), deal push, and Q2 expectations
• Key points:
  • Marcus Jewell: Q1 historically difficult (no global budget cycle end except Australia); HSI budget approved only in last days of quarter; some deals pushed but nothing lost — momentum into Q2/Q3.
  • David Barter added: unusually small pool of expirations; new products hit final 2 weeks of quarter limiting fulfillment.
  • Tom Hogan flagged larger federal deals in pipeline — "bigger deals than we've ever seen."
  • Marcus noted framework changes push orders to regions; win backs from delayed budget expected; increasing deal size may require customers to secure other budgets, causing slight delays.
• Mgmt stance: Bullish — strong pipeline with larger deals, sequential growth expected in Q2/Q3; no deals lost.

Q4 — Jonathan Ho

• Topic: Spending environment, macro events, budget flush potential
• Key points:
  • Tom Hogan: Global events are tailwind (Iran War no negative impact; Asia, India specific color); over $30M extra in appropriations for a few US agencies (from FYSA websites), targeting ATO approved cloud storage solution — Cellebrite is only FedRAMP Level 4 Certified forensic cloud solution.
  • Marcus Jewell: D&I budget expansion "hyperbolic"; appropriations bills now target their solution specifically; having ATO certification (vs. "in process") is key for conversion.
• Mgmt stance: Bullish — political/geopolitical instability and border issues play to company strengths; specific appropriations provide clear revenue conversion path.